跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TH 1-9
首页
药物
TH 1-9
TH 1-9
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DNA BINDING PROTEIN USING PPR MOTIF, AND USE THEREOF
申请人: UNIV KYUSHU NAT UNIV CORP
优先权: 2013
CN
WO
8 件公开
Methods and compositions for treating and preventing inflammatory conditions
申请人: DRIVAS DIMITRIOS T
优先权: 2003
CN
US
2 件公开
Mutants of igf binding proteins and methods of production of antagonists thereof
申请人: BEISEL HANS-GEORG
优先权: 2001
US
Intermediates for and synthesis of 3-methylene cephams
申请人: COOPER ROBIN D G
优先权: 2001
US
Gene cloning of polyepitope antigen of hepatitis C virus and its coding sequence
申请人: UNIV PLA 2ND MILITARY MEDICAL
优先权: 2004
CN
Helicobacter Pylori urease B subunit Th epitope peptide, its coding DNA, vaccine and uses
申请人: PLA 3RD MILITARY MEDICAL UNIV
优先权: 2006
CN
New 4-substituent-1-dehydroxy baccatin VI derivative and its preparing method
申请人: UNIV SHANGHAI
优先权: 2006
CN
PHENANTHROLINE COMPOUND, ELECTRON TRANSPORT MATERIAL OBTAINED FROM SAID COMPOUND, AND ORGANIC THIN-FILM PHOTOVOLTAIC CELL COMPRISING SAID COMPOUND
申请人: IDEMITSU KOSAN CO
优先权: 2010
EP
一类前列腺癌靶向的药物前体及其合成方法
申请人: 原子高科股份有限公司
优先权: 2021
CN
Stapling peptide of targeted pan-Ras protein and application
申请人: SECOND MILITARY MEDICAL UNIV
优先权: 2022
CN
药物
反馈